Keywords: nipent, alpha-2a, ifn, compared, leukemia, warner-lambert, anticancer

NIPENT AND ALPHA-2a IFN COMPARED IN LEUKEMIA

Article | 01 June 1992

Warner-Lambert's anticancer agent Nipent (pentostatin) has been favorably compared with Roche's Roferon A (alpha-2a interferon) in clinical studies involving ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Alpha

Prolastin

Go to drug listing